Search - tctmd.com

Displaying 581 - 600 of 922

Sort: Relevancy | Date

News Daily News

“外科-介入合作”方法的支持者Michael J. Davidson去世，享年44岁

Yael L. Maxwell

January 28, 2015

News Daily News

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Salynn Boyles

December 11, 2014

News Daily News

SORT OUT III亚组研究揭示了DES疗效随糖尿病状态的变化

Todd Neale

November 17, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Todd Neale

November 17, 2014

News Featured Fellow

Jonathan Soverow, MD, MPH

Yael L. Maxwell

November 05, 2014

Presentation TCT 2014

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka

September 16, 2014

Presentation TCT 2014

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud

September 16, 2014

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Summary of Current US and EU Guidelines and AUC for Left Main Revascularization: Consistencies and Gaps

Presenter: Jean Fajadet, Marie-Claude Morice, Margaret B. McEntegart, Ajay J. Kirtane

September 16, 2014

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

$PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura$

Presentation TCT 2014

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, David Hildick-Smith

September 16, 2014

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Conference News TCT 2014

PRIMA: PFO Closure Fails to Reduce Number of Migraine Days at 1 Year

Yael L. Maxwell

September 16, 2014

Presentation TCT 2014

Case Presentation Conclusion: How and Why Did We Treat? What Were the Outcomes?

Presenter: Ajay J. Kirtane, David Taggart, Molly Szerlip

September 15, 2014

Presentation TCT 2014

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

Presenter: Ajay J. Kirtane, David Taggart, David J. Maron

September 15, 2014

Presentation TCT 2014

Forget Hybrid Do the Whole Thing Robotically!

Presenter: Ajay J. Kirtane, David Taggart, Michael DECEASED J. Davidson

September 15, 2014

Presentation TCT 2014

PCI Is Just as Good as CABG for This Patient but Lower Risk!

Presenter: Ajay J. Kirtane, David Taggart

September 15, 2014

Presentation TCT 2014

Case Presentation: An Asymptomatic Patient with a Positive Stress Test and Focal Three Vessel Disease

Presenter: Ajay J. Kirtane, David Taggart, Molly Szerlip

September 15, 2014

Advertisement

“外科-介入合作”方法的支持者Michael J. Davidson去世，享年44岁

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

SORT OUT III亚组研究揭示了DES疗效随糖尿病状态的变化

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Jonathan Soverow, MD, MPH

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Summary of Current US and EU Guidelines and AUC for Left Main Revascularization: Consistencies and Gaps

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

PRIMA: A Prospective, Randomized Trial of PFO Closure in Patients with Refractory Migraine with Aura

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

PRIMA: PFO Closure Fails to Reduce Number of Migraine Days at 1 Year

Case Presentation Conclusion: How and Why Did We Treat? What Were the Outcomes?

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

Forget Hybrid Do the Whole Thing Robotically!

PCI Is Just as Good as CABG for This Patient but Lower Risk!

Case Presentation: An Asymptomatic Patient with a Positive Stress Test and Focal Three Vessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content